Seoul Pharma Co., Ltd (KOSDAQ:018680)
South Korea · Delayed Price · Currency is KRW 1,798.00
0.00 (0.00%)
At close: Nov 13, 2026
Seoul Pharma Market Cap
Seoul Pharma has a market cap or net worth of 20.96 billion as of November 13, 2026. It is the 38,400th most valuable company in the world and the 2,347th biggest in South Korea. Its market cap has decreased by 41.43% in one year.
Market Cap
20.96B
Enterprise Value
19.20B
Revenue
51.08B
Global Rank
Country Rank
#2,347 South Korea
PE Ratio
12.06
ChartMarket Cap Chart
Since March 1, 2001, Seoul Pharma's market cap has increased from 20.00B to 20.96B, an increase of 4.82%. That is a compound annual growth rate of 0.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 20.96B | -41.62% |
| Dec 30, 2025 | 35.91B | -6.95% |
| Dec 30, 2024 | 38.59B | -13.58% |
| Dec 28, 2023 | 44.66B | -23.86% |
| Dec 29, 2022 | 58.65B | -12.36% |
| Dec 30, 2021 | 66.92B | -28.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kyung Nam Pharm | 30.02B |
| HLscience | 29.95B |
| Korea Arlico Pharm | 29.12B |
| Pharmsville | 25.89B |
| Baskhanbio Pharma | 24.49B |
| Daesung Microbiological Labs. | 20.14B |
| Union Korea Pharm | 19.70B |
| BIFIDO | 19.30B |